Acquisition by Obyrne Jason of 33000 shares of Caribou Biosciences subject to Rule 16b-3

CRBU Stock  USD 1.31  0.03  2.24%   
Slightly above 64% of Caribou Biosciences' investor base is looking to short. The analysis of the overall investor sentiment regarding Caribou Biosciences suggests that many traders are alarmed. Caribou Biosciences' investing sentiment can be driven by a variety of factors including economic data, Caribou Biosciences' earnings reports, geopolitical events, and overall market trends.
  
Filed transaction by Caribou Biosciences Officer: Chief Financial Officer. Grant, award or other acquisition pursuant to Rule 16b-3(d)

Read at macroaxis.com
Caribou insider trading alert for acquisition of common stock by O'byrne Jason, Officer: Chief Financial Officer, on 29th of August 2024. This event was filed by Caribou Biosciences with SEC on 2024-02-20. Statement of changes in beneficial ownership - SEC Form 4

Cash Flow Correlation

Caribou Biosciences' cash-flow correlation analysis can be used to evaluate the unsystematic risk during the given period. It also helps investors identify the Caribou Biosciences' relationships between the major components of the statement of changes in financial position and other commonly used cash-related accounts. When such correlations are discovered, they may help managers and analysts to enhance performance or determine appealing investment opportunities.
Click cells to compare fundamentals

Caribou Biosciences Investor Sentiment by Other News Outlets

Investor sentiment, mood or attitude towards Caribou Biosciences can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.

Caribou Biosciences Historical Investor Sentiment

Investor biases related to Caribou Biosciences' public news can be used to forecast risks associated with an investment in Caribou. The trend in average sentiment can be used to explain how an investor holding Caribou can time the market purely based on public headlines and social activities around Caribou Biosciences. Please note that most equities that are difficult to arbitrage are affected by market sentiment the most.
Caribou Biosciences' market sentiment shows the aggregated news analyzed to detect positive and negative mentions from the text and comments. The data is normalized to provide daily scores for Caribou Biosciences and other traded tickers. The bigger the bubble, the more accurate the estimated score. Higher bars for a given day show more participation in the average Caribou Biosciences news discussions. The higher the estimate score, the more favorable the investor's outlook on Caribou Biosciences.

Caribou Biosciences Fundamental Analysis

We analyze Caribou Biosciences' financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Caribou Biosciences using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Caribou Biosciences based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.

Market Capitalization

Market Capitalization Comparative Analysis

Caribou Biosciences is currently under evaluation in market capitalization category among its peers. Market Capitalization is the total market value of a company's equity. It is one of many ways to value a company and is calculated by multiplying the price of the stock by the number of shares issued. If a firm has one type of stock its market capitalization will be the current market share price multiplied by the number of shares. However, if a company has multiple types of equities then the market cap will be the total of the market caps of the different types of shares.

Caribou Biosciences Potential Pair-trading

One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Caribou Biosciences stock to make a market-neutral strategy. Peer analysis of Caribou Biosciences could also be used in its relative valuation, which is a method of valuing Caribou Biosciences by comparing valuation metrics with similar companies.

Peers

Caribou Biosciences Related Equities

SANASana Biotechnology   7.38   
0%
100.0%
BEAMBeam Therapeutics   5.29   
0%
71.0%
FATEFate Therapeutics   4.58   
0%
62.0%
PRMEPrime Medicine,   2.91   
0%
39.0%
EDITEditas Medicine   2.24   
0%
30.0%
CRSPCrispr Therapeutics   2.01   
0%
27.0%
ADPTAdaptive Biotechnologies   1.95   
0%
26.0%
NTLAIntellia Therapeutics   1.10   
0%
14.0%
VERVVerve Therapeutics   3.77   
51.0%
0%

Additional Tools for Caribou Stock Analysis

When running Caribou Biosciences' price analysis, check to measure Caribou Biosciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Caribou Biosciences is operating at the current time. Most of Caribou Biosciences' value examination focuses on studying past and present price action to predict the probability of Caribou Biosciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Caribou Biosciences' price. Additionally, you may evaluate how the addition of Caribou Biosciences to your portfolios can decrease your overall portfolio volatility.